P2.01-007 Molecular Characterization of Non-Small Cell Lung Cancers (NSCLC) in Young Patients from an Argentine Population  V. Denninghoff, G. Recondo,

Slides:



Advertisements
Similar presentations
Massive Bronchogenic Cyst Joseph B. Levin, BA, Chi Wan Koo, MD, Jessica S. Donington, MD Journal of Thoracic Oncology Volume 5, Issue 11, Pages
Advertisements

A2-06: Survival differences for non-Bronchioloalveolar Carcinoma (BAC) non-small-cell lung cancer (NSCLC) cases with ipsilateral intrapulmonary metastasis.
Carcinoma NOS is a Common Histologic Diagnosis and is Increasing in Proportion Among Non-small Cell Lung Cancer Histologies  Sai-Hong Ignatius Ou, MD,
Prognostic Significance of the Number of Lymph Nodes Removed at Lobectomy in Stage IA Non-small Cell Lung Cancer  Sai-Hong Ignatius Ou, MD, PhD, Jason.
SC17.02 Lung Cancer in China: Challenges and Perspectives
OA Mediastinal Staging by Videomediastinoscopy in Clinical N1 Non-Small Cell Lung Cancer: a Prospective Multicenter Study  H. Decaluwe, C. Dooms,
APLCC ORAL ABSTRACT SESSIONS - MONDAY, NOVEMBER 26
Susan C. Scott, MD, Nathan A. Pennell, MD, PhD 
MA12.06 Tumor Spread through Air Spaces (STAS) in Lung Squamous Cell Cancer is an Independent Risk Factor: A Competing Risk Analysis  Shaohua Lu, Takashi.
NA  Journal of Thoracic Oncology 
Electronic Updates for JTO Readers
IA05.01 Lung Cancer Cases Journal of Thoracic Oncology
P The Effect of Two Interventions on Attainment of Surgical Quality Measures in Resected Non-Small Cell Lung Cancer (NSCLC)  Nicholas Faris, Meredith.
The International Association for the Study of Lung Cancer International Staging Project on Lung Cancer  Peter Goldstraw, MB, FRCS, John J. Crowley, PhD 
The Influence of the Evolution of First-Line Chemotherapy on Steadily Improving Survival in Advanced Non-Small-Cell Lung Cancer Clinical Trials  Krista.
Mediastinal Lymph Node Examination and Survival in Resected Early-Stage Non– Small-Cell Lung Cancer in the Surveillance, Epidemiology, and End Results.
Variations in Receipt of Curative-Intent Surgery for Early-Stage Non–Small Cell Lung Cancer (NSCLC) by State  Helmneh M. Sineshaw, MD, MPH, Xiao-Cheng.
Association between Congenital Lung Malformations and Lung Tumors in Children and Adults: A Systematic Review  Arianna Casagrande, MD, Federica Pederiva,
Erik Jakobsen, Maria Iachina, Karen Ege Olsen, Anders Green 
P SARON: Stereotactic Ablative Radiotherapy for Oligometastatic Non-Small Cell Lung Cancer (NSCLC). A UK Randomized Phase III Trial  Yenting Ngai,
P3.02c-026 Is Nivolumab Safe and Effective in Elderly and PS2 Patients with Non-Small Cell Lung Cancer (NSCLC)? Results of CheckMate 153  David Spigel,
P3.02b-125 Failure to Tyrosine Kinase Inhibitors and Patterns of Progression in Patients with Advanced Non-Small Cell Lung Cancer  Feliciano Barron, Laura-Alejandra.
Strategies to Improve Outcomes of Patients with EGFR-Mutant Non–Small Cell Lung Cancer: Review of the Literature  Caicun Zhou, MD, PhD, Luan Di Yao, MD 
P3.02b-075 Addition of Bevacizumab for Malignant Pleural Effusion as the Manifestation of Acquired EGFR-TKI Resistance in NSCLC Patients  Tao Jiang, Shengxiang.
PD-L1 as a Companion Biomarker for Immune Checkpoint Inhibitors in NSCLC: Should RNA ISH (RISH) Be Considered?  Steven G. Gray, PhD  Journal of Thoracic.
P3.02b-062 Safety of Necitumumab and Abemaciclib Combination Therapy in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)  Benjamin Besse, Johan.
P Predictors of Survival after Whole Brain Radiotherapy for Patients with Brain Metastasized Lung Cancer  Georgios Tsakonas, Fatou Hellman, Signe.
Daniel Morgensztern, MD, Boone Goodgame, MD, Maria Q
PS02.17 A Biomarker-Driven Algorithm for Sequencing of Systemic Therapy for Metastatic Non-Small Cell Lung Cancer (mNSCLC): A Survey of 25 Investigators 
Nivolumab-Induced Acute Diabetes Mellitus and Hypophysitis in a Patient with Advanced Pulmonary Pleomorphic Carcinoma with a Prolonged Tumor Response 
Elizabeth Cathcart-Rake, MD, Ariel Lopez-Chavez, MD, MS 
Vamsidhar Velcheti, MD  Journal of Thoracic Oncology 
Heidi B. Rolke, Frode Gallefoss  Journal of Thoracic Oncology 
Mitotic Inhibitors Journal of Thoracic Oncology
JCSE01.16 Positive Correlation Between Whole Genomic Copy Number Variant Scoring and the Grading System in Lung Non-Mucinous Invasive Adenocarcinoma 
PD5-1-7: Time trends in nodal CT volume and nodal motion during radiotherapy for patients with stage III non-small cell lung cancer  Geert Bosmans, Angela.
Mirror Mirror on the Wall, Who Is the Fairest of Them All
ES Lung Cancer Surgery for High Risk Patients
P Circulating Biomarkers of Frailty Are Associated with a Poor Prognosis in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)  Nicola.
The Number of Pulmonary Metastases: Influence on Practice and Outcome
A1-02: A need to standardize post-operative radiotherapy (PORT) fields used for non- small cell lung cancer (NSCLC): analysis of an international dummy-run.
MTP13-01: Indications and limitations of bronchoscopy
Trends in Stage Distribution for Patients with Non-small Cell Lung Cancer: A National Cancer Database Survey  Daniel Morgensztern, MD, Shean Huey Ng,
MA Comparison of EORTC, PERCIST, PeterMac & Deauville PET Response Criteria after Radical ChemoRT in Non-Small-Cell Lung Cancer  G. Turgeon, A.
P3.02a-023 Treatment Patterns and Early Outcomes of ALK+ Non-Small Cell Lung Cancer Patients Receiving Ceritinib: A Chart Review Study  Edmond Bendaly,
A2-06: Survival differences for non-Bronchioloalveolar Carcinoma (BAC) non-small-cell lung cancer (NSCLC) cases with ipsilateral intrapulmonary metastasis.
M. Kusumoto  Journal of Thoracic Oncology 
Bretta M. McCall, Candice L. Wilshire, Hannah E. Modin, Joelle T
MINI01.08: Disparities in the Management of Patients with Stage I Small Cell Lung Cancer (SCLC): A Surveillance, Epidemiology and End Results (SEER) Analysis 
International Thymic Malignancies Interest Group: A Way Forward
P Impact of Systematic EBUS-TBNA Mediastinal Staging on Radical Radiotherapy Planning in NSCLC  N. Hardcastle, A. Cole, G. Turgeon, R. Thomas,
European Lung Cancer Conference (ELCC) 2016 Organisation
OA Video-Assisted Thoracoscopic Surgery vs
P2.03b-002 Efficacy and Safety of WBRT Combined with Endostar in Patients with Advanced Non-Small Cell Lung Cancer  Xiaorong Dong, Ruiguang Zhang, Xican.
PS01.07 The Clinical Necessity of Extended Thymectomy for Thymic Squamous Cell Carcinomas Revealed by Exome Sequencing  J. Jiang, Y. Zhang, C. Jin, J.
3A.01 Efficacy of Programmatic Combined Stereotactic Ablative Radiotherapy and Anti- PD-1 Therapy in Advanced Lung Cancer: A Retrospective Analysis  A.
IASLC 6th Latin American Conference on Lung Cancer
PS01.37: Comparison Between Sanger Sequencing and ARMS qPCR Method for EGFR Gene Mutation Detection of Non–Small Cell Lung Cancer  Jiexia Zhang, Xiaoshun.
P Clinical Consequences, Quality of Life, and Management of Neutropenic NSCLC Patients in the REVEL Trial  D. Ettinger, O. Arrieta, N. Karaseva,
OA Survival Trends Among Non-Small Cell Lung Cancer (NSCLC) Patients Over A Decade: Impact of Initial Therapy at Academic Centers  B. Dholaria,
APLCC POSTER SESSION 2 - WEDNESDAY, NOVEMBER 28
M. Pasquinelli, Z. Deliu, D. Rosenberg, C. Weldon, S. Obilade, A
Journal of Thoracic Oncology
Epidemiology of Thymoma and Associated Malignancies
P1. 02: Lung Cancer - A Previously Years Survival Study
Population-Based Patterns of Surgical Care for Stage IIIA NSCLC in the Netherlands between 2010 and 2013  Chris Dickhoff, MD, Max Dahele, MBChB., PhD,
A Review of First-Line Treatment for Small-cell Lung Cancer
Mark A. Socinski, MD  Journal of Thoracic Oncology 
Y. Lou, R. Manochakian, J. Cochuyt, D. Hodge, S. Ailawadhi 
Robert Comis, MD, The Passing of a “Lung Man”
Presentation transcript:

P2.01-007 Molecular Characterization of Non-Small Cell Lung Cancers (NSCLC) in Young Patients from an Argentine Population  V. Denninghoff, G. Recondo, M. Cuello, M.M. García Falcone, V. Romano, M. Greco, V. Wainsztein, F. Galanternik, M. De La Vega, E. Rojas Bilbao, M.A. Avagnina, G. Recondo  Journal of Thoracic Oncology  Volume 12, Issue 11, Pages S2071-S2072 (November 2017) DOI: 10.1016/j.jtho.2017.09.1109 Copyright © 2017 Terms and Conditions

Journal of Thoracic Oncology 2017 12, S2071-S2072DOI: (10.1016/j.jtho.2017.09.1109) Copyright © 2017 Terms and Conditions